Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Current Liabilities (2020 - 2025)

Core Scientific's Total Current Liabilities history spans 6 years, with the latest figure at $562.7 million for Q2 2025.

  • For Q2 2025, Total Current Liabilities rose 652.06% year-over-year to $562.7 million; the TTM value through Jun 2025 reached $562.7 million, up 652.06%, while the annual FY2024 figure was $134.6 million, 72.45% down from the prior year.
  • Total Current Liabilities for Q2 2025 was $562.7 million at Core Scientific, up from $195.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.3 billion in Q3 2022 and bottomed at $827616.0 in Q1 2021.
  • The 5-year median for Total Current Liabilities is $195.5 million (2025), against an average of $289.5 million.
  • The largest annual shift saw Total Current Liabilities skyrocketed 80072150.0% in 2021 before it tumbled 75.74% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $320.3 million in 2021, then tumbled by 41.68% to $186.8 million in 2022, then soared by 161.48% to $488.4 million in 2023, then crashed by 72.45% to $134.6 million in 2024, then skyrocketed by 318.19% to $562.7 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Total Current Liabilities are $562.7 million (Q2 2025), $195.5 million (Q1 2025), and $134.6 million (Q4 2024).